- Home Page
- Company Profile
-
Our Products
- Anti Cancer Capsule
-
Anti Cancer Injection
- 300 mcg Filgrastim Injection
- Nimotuzumab Injection
- 2 Mg Bortezomib Injection
- 440 mg Trastuzumab Injection
- 40 mcg Darbepoetin Alfa Injection
- 1000 mg Gemcitabine Injection
- 38 mg Gemcitabine Injection
- 300 mcg Filgrastim Injection
- 260 mg Paclitaxel Injection
- 450 mg Carboplatin Injection
- 3.75 mg Leuprolide Acetate Injection
- 6 mg Pegfilgrastim Injection
- Pegfilgrastim Injection
- Anti Cancer Tablet
- Anti Cancer Medicine
- Nefroglogy Medicine
- HIV Medicine
- Contact Us
X
3.75 mg Leuprolide Acetate Injection
1800.00 - 2000.00 INR/Box
Product Details:
- Drug Type General Medicines
- Function Anti-Cancer
- Dosage As per doctor Recommendation
- Suitable For Suitable For All
- Storage Instructions Dry place
- Click to view more
X
Price And Quantity
- 25 Box
- 1800.00 - 2000.00 INR/Box
Product Specifications
- General Medicines
- Anti-Cancer
- Dry place
- Suitable For All
- As per doctor Recommendation
Trade Information
- AS per Requirement Per Month
- As per Location Days
- Yes
- Contact us for information regarding our sample policy
- All India
Product Description
3.75 mg Leuprolide Acetate Injection that is ideal for Intramuscular / Subcutaneous use, and for single use only. This is not for intravenous administration. Procured from trusted yet regular pharmaceutical dealers, this is used in the treatment of disorders of the uterus in women like endometriosis, fibroids. The 3.75 mg Leuprolide Acetate Injection helps decrease symptoms like painful/heavy menstrual periods, pelvic pain, and abdominal bloating. Also, it shrinks the uterine tissue of abnormal which causes these symptoms.
Other Products in 'Anti Cancer Injection' category
Contact Details
GALAXY LIFE CARE
Plot No 8, Office No 301, 3rd Floor, Chopra Commercial Complex, Delhi - 110092, India
Mr Gopal Jha
(Proprietor)
|
|
|
 |
|
Getdistributors.comSME TimesBlog
India's Largest B2B Marketplace, Connecting Buyers and Sellers.
Privacy Policy- Terms of Use © 1999-2017 Infocom Network Limited. All rights reserved.